121 related articles for article (PubMed ID: 10366100)
1. Dominant-negative p53 mutations in rheumatoid arthritis.
Han Z; Boyle DL; Shi Y; Green DR; Firestein GS
Arthritis Rheum; 1999 Jun; 42(6):1088-92. PubMed ID: 10366100
[TBL] [Abstract][Full Text] [Related]
2. Responses to the proinflammatory cytokines interleukin-1 and tumor necrosis factor alpha in cells derived from rheumatoid synovium and other joint tissues involve nuclear factor kappaB-mediated induction of the Ets transcription factor ESE-1.
Grall F; Gu X; Tan L; Cho JY; Inan MS; Pettit AR; Thamrongsak U; Choy BK; Manning C; Akbarali Y; Zerbini L; Rudders S; Goldring SR; Gravallese EM; Oettgen P; Goldring MB; Libermann TA
Arthritis Rheum; 2003 May; 48(5):1249-60. PubMed ID: 12746898
[TBL] [Abstract][Full Text] [Related]
3. Novel human p53 mutations that are toxic to yeast can enhance transactivation of specific promoters and reactivate tumor p53 mutants.
Inga A; Resnick MA
Oncogene; 2001 Jun; 20(26):3409-19. PubMed ID: 11423991
[TBL] [Abstract][Full Text] [Related]
4. TNF-alpha induced p21(WAF1) but not Bax in colon cancer cells WiDr with mutated p53: important role of protein stabilization.
Kobayashi N; Takada Y; Hachiya M; Ando K; Nakajima N; Akashi M
Cytokine; 2000 Dec; 12(12):1745-54. PubMed ID: 11097743
[TBL] [Abstract][Full Text] [Related]
5. Exogenous mutant p53 DNA enhanced cisplatin-induced apoptosis in TSGH-8301 human bladder cancer cells.
Chang FL; Ling YF; Lai MD
Anticancer Res; 2000; 20(1A):329-36. PubMed ID: 10769676
[TBL] [Abstract][Full Text] [Related]
6. Induction of apoptosis by the p53-273L (Arg --> Leu) mutant in HSC3 cells without transactivation of p21Waf1/Cip1/Sdi1 and bax.
Kaneuchi M; Yamashita T; Shindoh M; Segawa K; Takahashi S; Furuta I; Fujimoto S; Fujinaga K
Mol Carcinog; 1999 Sep; 26(1):44-52. PubMed ID: 10487521
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of the NF-kappa B transcription factor increases Bax expression in cancer cell lines.
Bentires-Alj M; Dejardin E; Viatour P; Van Lint C; Froesch B; Reed JC; Merville MP; Bours V
Oncogene; 2001 May; 20(22):2805-13. PubMed ID: 11420692
[TBL] [Abstract][Full Text] [Related]
8. p53 tumor suppressor gene mutations in fibroblast-like synoviocytes from erosion synovium and non-erosion synovium in rheumatoid arthritis.
Yamanishi Y; Boyle DL; Green DR; Keystone EC; Connor A; Zollman S; Firestein GS
Arthritis Res Ther; 2005; 7(1):R12-8. PubMed ID: 15642132
[TBL] [Abstract][Full Text] [Related]
9. Expression of the apoptosis accelerator Bax in rheumatoid arthritis synovium.
Hilbers I; Hansen T; Petrow PK; Gaumann A; Bräuer R; Salzmann G; Gay RE; Kosmehl H; Kirkpatrick CJ; Gay S; Kriegsmann J
Rheumatol Int; 2003 Mar; 23(2):75-81. PubMed ID: 12634940
[TBL] [Abstract][Full Text] [Related]
10. Bcl-2/Bax protein ratio predicts 5-fluorouracil sensitivity independently of p53 status.
Mirjolet JF; Barberi-Heyob M; Didelot C; Peyrat JP; Abecassis J; Millon R; Merlin JL
Br J Cancer; 2000 Nov; 83(10):1380-6. PubMed ID: 11044365
[TBL] [Abstract][Full Text] [Related]
11. Targeted point mutations of p53 lead to dominant-negative inhibition of wild-type p53 function.
de Vries A; Flores ER; Miranda B; Hsieh HM; van Oostrom CT; Sage J; Jacks T
Proc Natl Acad Sci U S A; 2002 Mar; 99(5):2948-53. PubMed ID: 11867759
[TBL] [Abstract][Full Text] [Related]
12. Development and validation of sensitive assays to quantitate gene expression after p53 gene therapy and paclitaxel chemotherapy using in vivo dosing in tumor xenograft models.
Wen SF; Xie L; McDonald M; DiGiacomo R; Chang A; Gurnani M; Shi B; Liu S; Indelicato SR; Hutchins B; Nielsen LL
Cancer Gene Ther; 2000 Nov; 7(11):1469-80. PubMed ID: 11129289
[TBL] [Abstract][Full Text] [Related]
13. PUMA regulation and proapoptotic effects in fibroblast-like synoviocytes.
Cha HS; Rosengren S; Boyle DL; Firestein GS
Arthritis Rheum; 2006 Feb; 54(2):587-92. PubMed ID: 16447235
[TBL] [Abstract][Full Text] [Related]
14. Involvement of the nuclear orphan receptor NURR1 in the regulation of corticotropin-releasing hormone expression and actions in human inflammatory arthritis.
Murphy EP; McEvoy A; Conneely OM; Bresnihan B; FitzGerald O
Arthritis Rheum; 2001 Apr; 44(4):782-93. PubMed ID: 11315917
[TBL] [Abstract][Full Text] [Related]
15. A conserved intronic response element mediates direct p53-dependent transcriptional activation of both the human and murine bax genes.
Thornborrow EC; Patel S; Mastropietro AE; Schwartzfarb EM; Manfredi JJ
Oncogene; 2002 Feb; 21(7):990-9. PubMed ID: 11850816
[TBL] [Abstract][Full Text] [Related]
16. The UV responsive elements in the human mimecan promoter: a functional characterization.
Tasheva ES; Conrad GW
Mol Vis; 2003 Jan; 9():1-9. PubMed ID: 12533723
[TBL] [Abstract][Full Text] [Related]
17. p53 mutants can often transactivate promoters containing a p21 but not Bax or PIG3 responsive elements.
Campomenosi P; Monti P; Aprile A; Abbondandolo A; Frebourg T; Gold B; Crook T; Inga A; Resnick MA; Iggo R; Fronza G
Oncogene; 2001 Jun; 20(27):3573-9. PubMed ID: 11429705
[TBL] [Abstract][Full Text] [Related]
18. Analysis of the p53 tumor suppressor gene in rheumatoid arthritis synovial fibroblasts.
Kullmann F; Judex M; Neudecker I; Lechner S; Jüsten HP; Green DR; Wessinghage D; Firestein GS; Gay S; Schölmerich J; Müller-Ladner U
Arthritis Rheum; 1999 Aug; 42(8):1594-600. PubMed ID: 10446856
[TBL] [Abstract][Full Text] [Related]
19. p53 triggers apoptosis in oncogene-expressing fibroblasts by the induction of Noxa and mitochondrial Bax translocation.
Schuler M; Maurer U; Goldstein JC; Breitenbücher F; Hoffarth S; Waterhouse NJ; Green DR
Cell Death Differ; 2003 Apr; 10(4):451-60. PubMed ID: 12719722
[TBL] [Abstract][Full Text] [Related]
20. NF-kappaB-regulated expression of cellular FLIP protects rheumatoid arthritis synovial fibroblasts from tumor necrosis factor alpha-mediated apoptosis.
Bai S; Liu H; Chen KH; Eksarko P; Perlman H; Moore TL; Pope RM
Arthritis Rheum; 2004 Dec; 50(12):3844-55. PubMed ID: 15593196
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]